All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
COEPTIS THERAPEUTICS INC. Last Reported: 10/31/2022 Stock Symbol:

Business Address

105 BRADFORD RD, SUITE 420

WEXFORD , PA US 15090

Mailing Address

105 BRADFORD RD, SUITE 420

WEXFORD , PA US 15090
Phone Number: 724-934-6467 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 11/30/2020 8/31/2020 6/30/2020 5/31/2020 3/31/2020 2/29/2020 12/31/2019 11/30/2019 8/31/2019
Cash and Cash Equivalents -- -- -- -- -- -- -- $4,938.00 $1,593.00 -- -- -- $9,146.00 $20,000.00 -- --
Accounts Receivable Net Current $8,075.00 -- -- -- $26,302.00 $21,786.00 $21,786.00 -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $7,378,984.00 $2,378,295.00 $2,343,829.00 $2,179,558.00 $2,836,164.00 $1,933,090.00 $2,056,515.00 -- -- -- -- -- -- -- -- --
Property Plant and Equipement $12,888.00 $13,234.00 $13,580.00 $13,926.00 $14,293.00 $14,660.00 $15,026.00 -- -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- $2,000.00 -- -- -- -- -- -- -- -- --
Total Assets $11,264,580.00 $6,523,645.00 $6,748,722.00 $6,765,576.00 $7,682,976.00 $2,738,290.00 $2,122,038.00 $4,938.00 $1,593.00 -- -- -- $9,146.00 $20,000.00 -- --
Accounts Payable $327,873.00 $268,465.00 $244,793.00 $134,092.00 $1,281,314.00 $2,746,627.00 $1,821,981.00 $4,777.00 -- -- -- -- $1,814.00 -- -- --
Accrued Liabilities $360,176.00 $305,652.00 $264,539.00 $199,126.00 $153,811.00 $196,401.00 $1,058,663.00 -- -- -- -- -- -- -- -- --
Total Current Liabilities $4,521,225.00 $4,462,611.00 $4,411,527.00 $4,414,942.00 $7,110,201.00 $4,878,623.00 -- $50,094.00 $38,444.00 -- -- -- $22,552.00 $20,150.00 -- --
Long Term Debt -- $150,000.00 $1,650,000.00 $1,650,000.00 $1,650,000.00 $150,000.00 $150,000.00 -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-62,181,367.00 $-56,532,658.00 $-46,729,821.00 $-27,550,126.00 $-24,710,518.00 $-18,764,162.00 $-16,050,927.00 $-526,090.00 $-36,851.00 -- -- -- $-13,405.00 $-150.00 -- --
Total Stockholders' Equity $6,743,355.00 $2,061,034.00 $2,337,195.00 $2,350,634.00 $572,774.00 $-2,140,332.00 $-3,713,985.00 $-45,156.00 $-36,851.00 $-1,924,126.00 $-23,103.00 $-1,572,822.00 $-13,405.00 $-150.00 -- --
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $11,264,580.00 $6,523,645.00 $6,748,722.00 $6,765,576.00 $7,682,976.00 $2,738,290.00 $2,122,038.00 $4,938.00 $1,593.00 -- -- -- $9,146.00 $20,000.00 -- --

Statement of Operations

Date 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 11/30/2020 8/31/2020 6/30/2020 5/31/2020 3/31/2020 2/29/2020 12/31/2019 11/30/2019 8/31/2019
Total Revenues -- -- -- $75,000.00 -- $75,000.00 $75,000.00 -- -- $20,874.00 -- $4,508.00 -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- $1,869.00 -- -- -- -- -- --
Gross Profit -- -- -- $75,000.00 -- $75,000.00 $75,000.00 -- -- $19,004.00 -- $4,508.00 -- -- -- --
Research and Development $20,887.00 -- -- -- -- -- -- -- -- $3,543.00 -- -- -- -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $31,152,697.00 $9,812,854.00 $15,771,134.00 $14,308,066.00 $6,947,898.00 $4,399,149.00 $1,775,081.00 $508,106.00 $20,740.00 $1,086,601.00 -- $400,907.00 -- $99.00 $99.00 $99.00
Loss from Operations $-31,152,697.00 $-25,583,988.00 $-15,771,134.00 $-14,233,066.00 $-6,947,898.00 $-4,324,149.00 $-1,700,081.00 $-508,106.00 $-20,740.00 $-1,067,597.00 -- $-396,399.00 -- $-99.00 $-99.00 $-99.00
Loss Before Income Taxes $-34,631,239.00 $-28,982,530.00 -- $-13,449,280.00 $-5,946,356.00 $-4,663,316.00 $-1,950,081.00 -- -- $-2,567,597.00 -- $-1,896,399.00 -- -- -- --
Earnings Per Share Basic -- $-0.25 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- 38,657,490 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- $-0.76 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- 38,042,870 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 750,000,000 750,000,000 750,000,000 750,000,000 750,000,000 750,000,000 750,000,000 750,000,000 750,000,000 -- -- -- 750,000,000 750,000,000 -- --
Common Stock Shares Outstanding 43,207,163 39,012,897 38,429,397 36,754,064 34,750,733 32,640,404 29,974,740 1,658,800 1,588,800 -- -- 16,396,000 1,588,800 1,588,800 -- --
Common Stock Value $4,196.00 $3,776.00 $3,718.00 $3,550.00 $3,317.00 $3,106.00 $2,839.00 $166.00 $24,904.00 -- -- -- $159.00 $159.00 -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- $0.00 $0.00 -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- 10,000,000 10,000,000 -- --
Preferred Stock Shares Outstanding -- -- -- -- 8,000 8,000 8,000 8,000 -- -- -- -- -- -- -- --
Preferred Stock Value $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 $1.00 -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- $0.00 $0.00 -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com